About
Senexbio is a drug discovery and development company focused on creating highly selective small-molecule inhibitors targeting proteins involved in cancer drug resistance and metastasis, aiming to treat incurable types of prostate cancer, breast cancer, and leukemia.
Explore Senexbio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.